Latest period
68.21M
YoY change
+40.8%
5Y CAGR
+42.2%
Peak year (2025)
67.81M
Latest annual
67.81M
Shares Outstanding history chart for Climb Bio (CLYM) from 2019 to 2025
Latest: 67.81M
Shares Outstanding growth chart for Climb Bio (CLYM) from 2019 to 2025
Latest: +40.8%
Shares Outstanding history table for Climb Bio (CLYM) from 2019 to 2025
| 2025 | 67.81M | +40.8% | +19.65M | ||
| 2024 | 48.16M | +78.5% | +21.18M | ||
| 2023 | 26.99M | +2.6% | +675,568 | ||
| 2022 | 26.31M | +114.6% | +14.05M | ||
| 2021 | 12.26M | +5.1% | +598,889 | ||
| 2020 | 11.66M | 0.0% | 0 | ||
| 2019 | 11.66M | — | — |
- 202567.81M+40.8%
- 202448.16M+78.5%
- 202326.99M+2.6%
- 202226.31M+114.6%
- 202112.26M+5.1%
- 202011.66M0.0%
- 201911.66M—
Shares Outstanding values are taken from Climb Bio's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at Climb Bio (CLYM)
According to Climb Bio's latest reported financial statements, the company's latest reported diluted shares outstanding is 68.21M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Climb Bio (CLYM) diluted shares outstanding totalled 67.81M – surged 40.8% year-over-year.
Through 2020–2025 (5 years), Climb Bio diluted shares outstanding delivered a +42.2% annualised rate; sustaining 5 straight years of year-over-year growth.
67.81M stands as the all-time-high annual diluted shares outstanding, posted in 2025, against a low of 11.66M during 2019.
Climb Bio Shares Outstanding by Year
Climb Bio Shares Outstanding 2025: 67.81M
2025's diluted shares outstanding for Climb Bio came in at 67.81M, surged 40.8% from 2024. This figure represents the highest annual value in the available history.
Climb Bio Shares Outstanding 2024: 48.16M
Climb Bio posted diluted shares outstanding of 48.16M in 2024, surged 78.5% from 2023.
Climb Bio Shares Outstanding 2023: 26.99M
In 2023, Climb Bio reported diluted shares outstanding of 26.99M, edged up 2.6% from 2022.
Climb Bio Shares Outstanding 2022: 26.31M
Climb Bio diluted shares outstanding in 2022 was 26.31M, surged 114.6% from 2021.
Climb Bio Shares Outstanding 2021: 12.26M
Climb Bio diluted shares outstanding in 2021 was 12.26M.
See more financial history for Climb Bio (CLYM).
Sector peers by Shares Outstanding
Healthcare peers of Climb Bio (CLYM), ranked by their latest diluted shares outstanding
| 4.45B | |
| 2.51B | |
| 2.43B | |
| 1.77B | |
| 1.56B | |
| 910.00M | |
| 898.00M | |
| 542.00M |
- 4.45B
- 2.51B
- 1.77B
- 1.56B
- 910.00M
- 898.00M
- 542.00M
Frequently asked questions
Climb Bio (CLYM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation